Cargando…

The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma

Urothelial carcinoma (UC) comprises the majority of bladder cancers. Standard platinum-based chemotherapy has a response rate of approximately 50%, but drug resistance develops after short-term treatment. Deubiquitinating (DUB) enzyme inhibitors increase protein polyubiquitination and endoplasmic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Po-Ming, Dong, Jun-Ren, Chang, Yu-Wei, Kuo, Kuan-Lin, Lin, Wei-Chou, Liu, Shing-Hwa, Huang, Kuo-How
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421311/ https://www.ncbi.nlm.nih.gov/pubmed/36090476 http://dx.doi.org/10.1016/j.omto.2022.08.004

Ejemplares similares

Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study
por: Kuo, Kuan-Lin, et al.
Publicado: (2019)

PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study
por: Hsu, Fu-Shun, et al.
Publicado: (2021)

The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
por: Kuo, Kuan-Lin, et al.
Publicado: (2019)

MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma
por: Ho, I-Lin, et al.
Publicado: (2015)

Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway
por: Hsu, Fu-Shun, et al.
Publicado: (2019)

Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells
por: Huang, Kuo-How, et al.
Publicado: (2013)

Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
por: Shi, Chung-Sheng, et al.
Publicado: (2019)

UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance
por: Jin, Chengmeng, et al.
Publicado: (2013)

Down-Regulation of Glucose-Regulated Protein (GRP) 78 Potentiates Cytotoxic Effect of Celecoxib in Human Urothelial Carcinoma Cells
por: Huang, Kuo-How, et al.
Publicado: (2012)

2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells
por: Kuo, Kuan-Lin, et al.
Publicado: (2013)

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)
por: Zhao, Yin, et al.
Publicado: (2020)

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer
por: Fukui, Shiho, et al.
Publicado: (2019)

UCHL1-PKM2 axis dysregulation is associated with promoted proliferation and invasiveness of urothelial bladder cancer cells
por: Zheng, Yuhui, et al.
Publicado: (2023)

Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency
por: Jiang, Zong-Yuan, et al.
Publicado: (2022)

MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis
por: Wu, Meng-Huang, et al.
Publicado: (2018)

Loss of UCHL1 rescues the defects related to Parkinson’s disease by suppressing glycolysis
por: Ham, Su Jin, et al.
Publicado: (2021)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
por: Wu, Chunjing, et al.
Publicado: (2005)

Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia
por: Jiang, Liling, et al.
Publicado: (2022)

Inhibition of the Cellular Deubiquitinase UCHL1 Suppresses SARS-CoV-2 Replication
por: Subramaniyan, Bharathiraja, et al.
Publicado: (2023)

Molecular Characterization and Expression Profiles of Sp-uchl3 and Sp-uchl5 during Gonad Development of Scylla paramamosain
por: Han, Kunhuang, et al.
Publicado: (2018)

Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Use of iTRAQ‐based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma
por: Lee, Ko‐Chao, et al.
Publicado: (2023)

Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway
por: Tsai, Te-Fu, et al.
Publicado: (2019)

A novel c.-652C>T mutation in UCHL1 gene is associated with the growth performance in Yangzhou goose
por: Wang, Qin, et al.
Publicado: (2021)

Human Papillomavirus (HPV) Upregulates the Cellular Deubiquitinase UCHL1 to Suppress the Keratinocyte's Innate Immune Response
por: Karim, Rezaul, et al.
Publicado: (2013)

UCHL1 regulates oxidative activity in skeletal muscle
por: Gao, Hongbo, et al.
Publicado: (2020)

Structural basis for specific inhibition of the deubiquitinase UCHL1
por: Grethe, Christian, et al.
Publicado: (2022)

The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer
por: Wang, Gongping, et al.
Publicado: (2015)

Response of the Urothelial Carcinoma Cell Lines to Cisplatin
por: Holíčková, Andrea, et al.
Publicado: (2022)

Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells
por: Wu, Dan-Dan, et al.
Publicado: (2023)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis
por: Li, Ruibing, et al.
Publicado: (2020)

Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches
por: Lee, Hsiang-Ying, et al.
Publicado: (2019)

Absence of UCHL 1 function leads to selective motor neuropathy
por: Genç, Barış, et al.
Publicado: (2016)

UCHL3 plays an important role in the occurrence and development of melanoma
por: He, Runzhi, et al.
Publicado: (2021)

Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
por: Liu, Shasha, et al.
Publicado: (2021)

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance
por: Cheng, Han-Ying, et al.
Publicado: (2022)

Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease
por: Carrieri, Claudia, et al.
Publicado: (2015)

Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
por: Zhou, Haiping, et al.
Publicado: (2016)

Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway
por: Prieto-Garcia, Cristian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7kekte3in04secjtg23jag49u9